We are Particle3D
We use proprietary technology to 3D print patient-fitted, degradable bone implants that remodel into real living bone.
In short: We Print Bone™.
We want to allow surgeons to provide bone implants that precisely match patient needs and streamline workflows, thereby improving patient outcomes and procedural efficiency while reducing costs.
For patients, this entails low risk of adverse effects, optimal functional and aesthetic outcomes and fast recovery.
Bone tissue reconstruction is a surgery performed millions of times each year, from congenital bone defects to victims of accidents and sufferers of diseases like cancer. Today, these patients receive harvested bone or live with titanium in their body for the rest of their lives.
Particle3D has developed a technology to reconstruct the patient’s exact anatomy with 3D printed patient-fitted implants with bone-like porosity. The implants are made from natural biomaterials which degrade over time and remodel into real living bone tissue.
Our implants can be designed to deliver additives, including growth factors, antibiotics and chemotherapy, which can be released over a controlled period of time. This usage will have wide ranging benefits for patients and health care providers.
Particle3D is founded on the invention Feedstock for 3D Printing and Uses Thereof and studies commenced in 2015 by the three founders: Casper Slots and Martin Bonde Jensen, both students from the University of Southern Denmark, and their Professor Morten Østergaard Andersen.
Their specific goal was to create a 3D printed implant solution for replacing destroyed or surgically removed bones — a solution far better than existing practices in terms of customization, precision and healing.
The P3D Business
We use this innovative technology to develop revolutionary bone implants, including implants that are designed to deliver additives such as pharmaceuticals and growth factors with wide ranging benefits for patients.
Our specific expertise within medical 3D printing is further used to provide a research product line of bone models wherein disease mechanisms can be studied and new treatments can be tested.
The technology is widely applicable and has the potential to be used with many materials and in a wide range of industries beyond the medical industry.
News from Particle3D
First step into the U.S. market Particle3D receives investment from New York based venture capital firm, Asimov Ventures, and enters valuable U.S. partnership. The partnership with Asimov Ventures marks the Company's first step into the U.S. market, looking toward an...read more
First Patent Approved Today, the European Patent Office announced that patent EP/3359318 for the Company's novel technology has been approved and published. The approval marks the first patent issuance which will be followed by continuations in parts originating from...read more
Particle3D is the winner of AMS Startup Competition, Boston, 2020! Particle3D attended the third annual Additive Manufacturing Strategies summit in Boston which, this year, evolved around the Business of 3D Printing: Medicine, Dentistry and Metals. On February 11th,...read more